Professional Documents
Culture Documents
Khusus
Sari
Pediatri,
Vol. 2, No. 4, Maret 2001
Alamat korespondensi:
Dr. Lina Herliana Soemara.
Divisi Surveilans & Epidemiologi P.T Bio Farma, Jalan Pasteur no. 28,
Bandung.
Tel. 022-2033755/2037430, Fax. 2037430/2041306.
E-mail: lina.soemara@biofarma.co.id
0,01%, berarti:
= 0,01 gram / 100 ml
= 10 2 x 10 6 ug / 10 2 ml
= 10 4 ug / 10 2 ml
= 100 ug / ml
= 50 ug / 0,5 ml
=
= food and drug administration
= agency for toxic substances and disease registry
= world health organization
Pernyataan William Egan PhD., Direktur Vaccine Research FDA di hadapan Committee
on Government Reform U.S House of Representatives pada tanggal 18 Juli 2000.9
217
Daftar Pustaka
1.
218
3.
4.
5.
6.
7.
Wakefield AJ, Murch SH, Anthony A dkk. Ileallymphoid-nodular hyperplasia, non-specific colitis, and
pervasive development disorder in children. Lancet 1998;
35:637-41.
Halsey NA. Limiting infant exposure to thimerosal in
vaccines and other sources of mercury. JAMA; 1999;
18:10.
Joint statement concerning removal of thimerosal from
vaccines - United States, http://www.cdc.gov/nip/vacsafe/
concerns/thimerosal.
Thiomersal as a vaccine preservative, Weekly Epidemiological Record, 2000; 2.
Thimerosal, Questions and answers provided for the
United States CDC, Atlanta, July 1999.
WHO Expert Committee on Biological Standardization,
Technical Report Series 1990; 800.
Thimerosal, a mercury-containing preservative used in
8.
9.
219